At a glance
ClinicalIndex Comparison RecordN/ACompleted· 197 enrolled
Drug / intervention
Glooko's mobile applicationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Glooko Diabetes Mobile Monitoring and Management Advantage Study
In Brief
A clinical study evaluating Glooko's mobile application for Diabetes Mellitus, Type 2. Completed, enrolled 197 participants across 4 sites.
Detailed Summary
The purpose of this study is to compare HbA1c of insulin-treated subjects with type 2 diabetes managed via usual care alone and usual care augmented with remote monitoring using Glooko
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Type 2
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedNov 2016
Enrollment StartMay 2017
Primary CompletionApr 2020
TodayJul 2026
First PostedNov 28, 2016
Enrollment StartMay 15, 2017
Primary CompletionApr 17, 2020
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 9.6 years ago
Interventions
Glooko's mobile applicationdevice
Standard of care and Remote monitoring